Experimental cancer drug could be effective in treating idiopathic pulmonary fibrosis
Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF). Saracatinib...
Experimental cancer drug could be effective in treating idiopathic pulmonary fibrosis
IRDiRC Forms Regulatory Science Committee to Address Regulatory Challenges in Rare Disease Research
High Court Judgement in the Matter De Wet and RDSA vs MediHelp and CMS
Health Squared: What Now?
MPS Warrior, Juan
Tuesdays with Eden
Determined Tina, our MS Warrior
Raising Aidan Powered by The Hemp Cream
Bailey’s Surprisingly (Un)Normal Normal Journey
Honouring Rare